ATHENS, Ohio--(BUSINESS WIRE)--Diagnostic HYBRIDS announces the release of its patented Super E-Mix cell line for enterovirus culture in the frozen ReadyCells® format. The availability of Super E-Mix in this novel format allows even the smallest clinical laboratory to offer the sensitivity and speed of rapid cell culture for diagnosis of enteroviral infection.
According to Patricia Harris, Executive Director of Worldwide Sales for Diagnostic HYBRIDS, “The ReadyCells platform was successfully launched in June 2002 with an initial release of R-Mix®, Hs27 and McCoy ReadyCells. These products have enabled clinical laboratories to perform cell culture for a large number of respiratory viruses including Influenza and RSV, herpes viruses including HSV-1, HSV-2, CMV and VZV, and other sexually transmitted diseases such as Chlamydia... read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment